Quality of life in people living with HIV in Aotearoa New Zealand: an exploratory cross-sectional study.

Quality of life (QoL) in people living with HIV (PLHIV) is reportedly worse than in people without HIV, with many factors impacting on this. We aimed to investigate QoL in PLHIV in New Zealand (NZ). In-person interviews were conducted including socio-demographic, health, social connectedness, and stigma-related questions. QoL was measured using the 13-question PozQoL Scale - summed to give a score between 13 and 65. Univariate linear regression was used to investigate factors associated with differences in PozQoL scores. PLHIV (n = 188) of different ethnicities from throughout NZ participated. The mean age was 47 years; 65% were men; 61% were men who have sex with men; 61% had been living with HIV for ≥10 years. The mean summary PozQoL score was 47.16. Factors associated with a lower mean PozQol included no sex in the last 12 months (-9.03), inability to meet basic needs (-7.47), ever (-6.49) or recently (-5.03), experiencing stigma or discrimination, mental health condition (-5.74), HIV diagnosis <5 years (-5.48), poor health (-5.43), being unemployed (-5.02), not having support (-4.71), and greater internalised stigma (-2.81). Improving QoL will require investment in peer support and community welfare programmes to better support PLHIV, and stigma reduction campaigns targeting the broader community.

Late presentation of HIV infection among adults in New Zealand from 2011 to 2020.

OBJECTIVES: Early diagnosis of HIV is essential for successful treatment and controlling HIV spread in a population. We examined the frequency and characteristics of adults diagnosed late with HIV in New Zealand from 2011-2020. METHODS: Routine surveillance data were analysed. Those previously diagnosed overseas or as part of immigration screening, or with missing CD4 count were excluded. 'Late presentation' was defined as a CD4 count <350 cells/µL or an AIDS-defining event. 'Advanced HIV disease' were those with a CD4 count <200 cells/µL or an AIDS-defining event. Relative risks were calculated using Poisson regression. RESULTS: Of 1145 people, 40.5% presented late; 24.9% had advanced HIV disease. Of the 464 late diagnoses, 65.5% occurred among men-who-have-sex-with-men (MSM), 26.1% among heterosexuals, 8.4% among others. Heterosexual men and women were more likely to present late (55.3%) compared to MSM (35.6%). Amongst MSM, those who were older, of an ethnicity other than European, acquired HIV overseas, tested because symptomatic, or had their last negative test >2 years prior were more likely to present late and have advanced disease. Amongst heterosexuals, older age, tested because symptomatic, and Pacific ethnicity were associated with late presentation, and Maori, Pacific and Asian people were more likely to have advanced disease. CONCLUSIONS: There continues to be a high proportion of people diagnosed late with HIV. Identifying barriers for testing, missed opportunities for screenings and other factors that delay HIV diagnosis could help develop effective strategies to reduce this burden of late presentation - particularly among heterosexual individuals, non-Europeans, and older people.

HIV in women in Aotearoa New Zealand: 25 years of surveillance data.

AIM: We describe the characteristics of women diagnosed with HIV and AIDS in Aotearoa New Zealand over the last 25 years, and of women living with HIV in New Zealand in order to guide the response for HIV prevention and care. METHODS: Data on women diagnosed with HIV and AIDS in New Zealand (1996-2020) were collected through routine surveillance case reports from healthcare providers. CD4 cell count <350 cells/mm³ was considered a late diagnosis. Women living with HIV by 31 December 2020 included those first diagnosed in New Zealand and those previously diagnosed overseas. RESULTS: A total of 634 women have been diagnosed with HIV (18% of all diagnoses in this time): most cases were acquired through heterosexual contact (82%). Twenty-eight percent (n=180/634) acquired HIV in New Zealand, of whom 43% were diagnosed late. AIDS was diagnosed in 128 women (72% within three months of HIV diagnosis). An estimated 570 women (77% aged >40 years) were living with diagnosed HIV at the end of 2020. CONCLUSION: The number of women diagnosed with HIV each year in New Zealand has remained steady over recent years. More timely testing and diagnosis is essential to ensure women with HIV have access to appropriate treatment and support.